Metered Dose Inhalers Market (Product Type: Manual Actuated pMDIs and Breath Actuated pMDIs; Disease Indication: Asthma, COPD, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Jan 2023| TMR3527A| Transparency

Report Highlights

Metered Dose Inhalers Market – Scope of Report

TMR’s report on the global metered dose inhalers market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global metered dose inhalers market for the period 2017–2031, considering 2022 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global metered dose inhalers market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the metered dose inhalers market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global metered dose inhalers market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global metered dose inhalers market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global metered dose inhalers market.

The report delves into the competitive landscape of the global metered dose inhalers market. Key players operating in the global metered dose inhalers market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global metered dose inhalers market profiled in this report.

RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market metered dose inhalers.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

  • Company websites, presentations, annual reports, white papers, technical paper, product brochure
  • Internal and external proprietary databases and relevant patents
  • National government documents, statistical databases, and market reports
  • News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

  • Industry Sources:
  • WorldWideScience.org
  • Elsevier, Inc.
  • National Institutes of Health (NIH)
  • PubMed
  • NCBI
  • Department of Health Care Service
  • Trade Data Sources
  • Trade Map
  • UN Comtrade
  • Trade Atlas
  • Company Information
  • OneSource Business Browser
  • Hoover’s
  • Factiva
  • Bloomberg
  • Mergers & Acquisitions
  • Thomson Mergers & Acquisitions
  • MergerStat
  • Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

  • Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
  • Helps in validating and strengthening secondary research findings
  • Further develops the analysis team’s expertise and market understanding
  • Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

  • Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
  • Purchasing/Sourcing managers, technical personnel, distributors
  • Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
  • Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

  • Advanced Oncotherapy PLC
  • Danfysik A/S
  • Hitachi, Ltd.
  • IBA Worldwide
  • Mevion Medical Systems, Inc.

Report Synopsis

Report Metrics Details
Base year considered 2022
Forecast period considered 2022-2031
Growth rate 3.10%
Units considered $ Million
Segments covered By Product Type, By Disease Indication, By Distribution Channel, By Region
Industry covered Healthcare
Countries covered North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Companies studied
  • AstraZeneca,
  • Boehringer Ingelheim,
  • Cipla Limited
  • Novartis AG,
  • Merck & Co., Inc.,
  • Sanofi,
  • Teva Pharmaceutical Industries Ltd.,
  • Hikma Pharmaceuticals plc,
  • Mylan N.V.,
  • GlaxoSmithKline

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others

Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

  • Table 1 : Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
  • Table 2 : Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2031
  • Table 3 : Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 4 : Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Region, 2017–2031
  • Table 5 : North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country, 2017–2031
  • Table 6 : North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
  • Table 7 : North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2031
  • Table 8 : North America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 9 : Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 10 : Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
  • Table 11 : Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2031
  • Table 12 : Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 13 : Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 14 : Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
  • Table 15 : Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2031
  • Table 16 : Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 17 : Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 18 : Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
  • Table 19 : Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2031
  • Table 20 : Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Table 21 : Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
  • Table 22 : Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Product Type, 2017–2031
  • Table 23 : Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Disease Indication, 2017–2031
  • Table 24 : Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031
  • Figure 1 : Global Metered Dose Inhalers Market Value (US$ Mn) Forecast, 2017–2031
  • Figure 2 : Global Metered Dose Inhalers Market Value Share, by Product Type, 2021
  • Figure 3 : Global Metered Dose Inhalers Market Value Share, by Distribution Channel, 2021
  • Figure 4 : Global Metered Dose Inhalers Market Value Share, by Disease Indication, 2021
  • Figure 5 : Global Metered Dose Inhalers Market Value Share, by Region, 2021
  • Figure 6 : Global Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 7 : Global Metered Dose Inhalers Market Value (US$ Mn), by Manual Actuated pMDIs, 2017–2031
  • Figure 8 : Global Metered Dose Inhalers Market Value (US$ Mn), by Breath Actuated pMDIs, 2017–2031
  • Figure 9 : Global Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022–2031
  • Figure 10 : Global Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 11 : Global Metered Dose Inhalers Market Value (US$ Mn), by Asthma, 2017–2031
  • Figure 12 : Global Metered Dose Inhalers Market Value (US$ Mn), by COPD, 2017–2031
  • Figure 13 : Global Metered Dose Inhalers Market Value (US$ Mn), by Others, 2017–2031
  • Figure 14 : Global Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022–2031
  • Figure 15 : Global Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 16 : Global Metered Dose Inhalers Market Value (US$ Mn), by Hospital Pharmacies, 2017–2031
  • Figure 17 : Global Metered Dose Inhalers Market Value (US$ Mn), by Retail Pharmacies, 2017–2031
  • Figure 18 : Global Metered Dose Inhalers Market Value (US$ Mn), by Online Pharmacies, 2017–2031
  • Figure 19 : Global Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 20 : Global Metered Dose Inhalers Market Value Share Analysis, by Region, 2021 and 2031
  • Figure 21 : Global Metered Dose Inhalers Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 22 : North America Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 23 : North America Metered Dose Inhalers Market Value Share (%), by Country, 2021 and 2031
  • Figure 24 : North America Metered Dose Inhalers Market Attractiveness Analysis, by Country, 2022–2031
  • Figure 25 : North America Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 26 : North America Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022–2031
  • Figure 27 : North America Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 28 : North America Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022–2031
  • Figure 29 : North America Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 30 : North America Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 31 : Europe Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 32 : Europe Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 33 : Europe Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 34 : Europe Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 35 : Europe Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022–2031
  • Figure 36 : Europe Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 37 : Europe Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022–2031
  • Figure 38 : Europe Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 39 : Europe Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 40 : Asia Pacific Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 41 : Asia Pacific Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 42 : Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 43 : Asia Pacific Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 44 : Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022–2031
  • Figure 45 : Asia Pacific Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 46 : Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022–2031
  • Figure 47 : Asia Pacific Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 48 : Asia Pacific Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 49 : Latin America Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 50 : Latin America Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 51 : Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 52 : Latin America Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 53 : Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022–2031
  • Figure 54 : Latin America Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 55 : Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022–2031
  • Figure 56 : Latin America Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 57 : Latin America Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 58 : Middle East & Africa Metered Dose Inhalers Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031
  • Figure 59 : Middle East & Africa Metered Dose Inhalers Market Value Share (%), by Country/Sub-region, 2021 and 2031
  • Figure 60 : Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
  • Figure 61 : Middle East & Africa Metered Dose Inhalers Market Value Share Analysis, by Product Type, 2021 and 2031
  • Figure 62 : Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Product Type, 2022–2031
  • Figure 63 : Middle East & Africa Metered Dose Inhalers Market Value Share Analysis, by Disease Indication, 2021 and 2031
  • Figure 64 : Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Disease Indication, 2022–2031
  • Figure 65 : Middle East & Africa Metered Dose Inhalers Market Value Share Analysis, by Distribution Channel, 2021 and 2031
  • Figure 66 : Middle East & Africa Metered Dose Inhalers Market Attractiveness Analysis, by Distribution Channel, 2022–2031
  • Figure 67 : Global Metered Dose Inhalers Market Share Analysis, by Company, 2021

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Transparency
Price: $5795

Become a Member

Already a member? Login here.

Have a Question? Ask Us.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
Custom Research

Need a custom data table, graph or complete report? Tell us more.

RELATED REPORTS